The ePlex system streamlines the diagnostic workflow from physician order entry to the final test report and is the only true sample-to-answer solution system designed to improve patient care, reduce costs, and increase lab efficiency. The ePlex System offers unique solutions to address the most significant challenges facing clinical laboratories, while supporting hospital systems to deliver patient-centered, value-based care. GenMark’s ePlex ® True Sample-to-Answer Solution ® System symbolizes the evolution of eSensor technology combined with digital microfluidics. GENMAC has been on the market since 1983 and now looks toward the future with a single inspiring motivation: to sell high quality power generators all over the world, helping all people do their jobs in any kind of environment, without forgoing safety. Kayyem currently serves as a strategic advisor to GenMark’s management and Board. Gleeson remained an integral part of GenMark’s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. GenMark’s ePlex ® True Sample-to-Answer Solution ® System symbolizes the evolution of eSensor technology combined with digital microfluidics. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. Kayyem became actively involved again in 2009, returning as an investor, and then as CEO and Chairman of the Board. Following several acquisitions of the technology, Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor ®” technology to disposable chips. His invention was based on electrical detection of nucleic acids on a cassette-based detection platform. This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. The ePlex BCID-FP Panel from GenMark Diagnostics, a member of the Roche corporation, is currently the largest commercial multiplex fungal pathogen. He played college football for Notre Dame and UCLA. In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). Jordan Genmark Heath (born December 16, 1997) is a Swedish professional gridiron football linebacker.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |